Coloplast A/S (OTCMKTS:CLPBY – Get Rating) had its price objective trimmed by JPMorgan Chase & Co. from 1,014.00 to 980.00 in a research report released on Tuesday, The Fly reports. The brokerage currently has a neutral rating on the stock.
Other analysts have also recently issued reports about the stock. DNB Markets raised shares of Coloplast A/S from a sell rating to a hold rating in a research note on Wednesday, January 26th. Barclays upped their target price on shares of Coloplast A/S from 975.00 to 990.00 in a research report on Monday, January 10th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of Hold and a consensus target price of $1,038.00.
OTCMKTS CLPBY opened at $12.10 on Tuesday. The stock has a market cap of $26.14 billion, a P/E ratio of 40.33 and a beta of 0.28. The company’s 50-day simple moving average is $14.32 and its 200 day simple moving average is $15.38. Coloplast A/S has a twelve month low of $11.71 and a twelve month high of $18.90. The company has a quick ratio of 0.90, a current ratio of 1.29 and a debt-to-equity ratio of 0.02.
Coloplast A/S Company Profile (Get Rating)
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
- Get a free copy of the StockNews.com research report on Coloplast A/S (CLPBY)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.